Beijing SL Pharmaceutical Co., Ltd. (SHE:002038)
China · Delayed Price · Currency is CNY 6.19
-0.09 (-1.43%)
May 20, 2026, 1:55 PM CST
Beijing SL Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -479.28 | -347.2 | -74.07 | 416.69 | 234.4 | 425.94 |
Depreciation & Amortization | 166.77 | 166.77 | 152.96 | 145.4 | 113.88 | 99.8 |
Other Amortization | 0.29 | 0.29 | 0.28 | 0.28 | 0.17 | 0.17 |
Loss (Gain) From Sale of Assets | 0.05 | 0.05 | - | - | -0.21 | -3.22 |
Asset Writedown & Restructuring Costs | -338.17 | -338.17 | 172.29 | -0.01 | 0 | 0.02 |
Loss (Gain) From Sale of Investments | -2.34 | -2.34 | -13.13 | -239.47 | -98.13 | -209.01 |
Provision & Write-off of Bad Debts | - | - | - | 23.81 | 31.94 | 26.25 |
Other Operating Activities | 246.51 | -0.23 | -0.66 | 1.05 | -5.99 | -4.38 |
Change in Accounts Receivable | -14.76 | -14.76 | 62.45 | 19.66 | 82.88 | 108.64 |
Change in Inventory | -436.26 | -436.26 | -102.33 | -4.25 | 0.58 | -11.5 |
Change in Accounts Payable | 544.68 | 544.68 | 68.51 | 66.58 | 36.56 | 17.54 |
Change in Other Net Operating Assets | 621.15 | 621.15 | 11.09 | - | - | - |
Operating Cash Flow | 372.31 | 257.66 | 225.49 | 460.2 | 389.82 | 464.63 |
Operating Cash Flow Growth | 493.35% | 14.27% | -51.00% | 18.05% | -16.10% | 11.73% |
Capital Expenditures | -67.5 | -192.97 | -347.38 | -218.36 | -163.49 | -236.91 |
Sale of Property, Plant & Equipment | 0 | 0 | 0 | 0.01 | 1.47 | 7.49 |
Divestitures | - | - | - | - | -4.88 | - |
Investment in Securities | 46.4 | 26.4 | -33.46 | -86.95 | -384.76 | -0.96 |
Other Investing Activities | 39.65 | 27.29 | 169.29 | -39.35 | 11.25 | 32.55 |
Investing Cash Flow | 18.55 | -139.28 | -211.55 | -344.65 | -540.4 | -197.82 |
Short-Term Debt Issued | - | - | - | - | - | 5.5 |
Total Debt Issued | - | - | - | - | - | 5.5 |
Short-Term Debt Repaid | - | - | - | - | - | -14.5 |
Long-Term Debt Repaid | - | - | - | - | - | -0.4 |
Total Debt Repaid | - | - | - | - | - | -14.9 |
Net Debt Issued (Repaid) | - | - | - | - | - | -9.4 |
Common Dividends Paid | -17.9 | -17.9 | -154.1 | -102.74 | -102.74 | -102.93 |
Other Financing Activities | 50 | - | - | - | - | 9 |
Financing Cash Flow | 32.1 | -17.9 | -154.1 | -102.74 | -102.74 | -103.33 |
Foreign Exchange Rate Adjustments | -0 | 0 | -0 | 0.03 | 0.1 | -0.02 |
Net Cash Flow | 422.96 | 100.49 | -140.17 | 12.84 | -253.21 | 163.45 |
Free Cash Flow | 304.81 | 64.69 | -121.89 | 241.84 | 226.33 | 227.72 |
Free Cash Flow Growth | - | - | - | 6.85% | -0.61% | 42.42% |
Free Cash Flow Margin | 51.52% | 10.37% | -18.46% | 23.75% | 21.55% | 18.75% |
Free Cash Flow Per Share | 0.30 | 0.06 | -0.12 | 0.24 | 0.22 | 0.22 |
Cash Income Tax Paid | 26.6 | 26.6 | 39.14 | 88.16 | 91.55 | 85.63 |
Levered Free Cash Flow | 935.11 | -36.59 | -260.4 | 186.77 | 121.34 | 113.97 |
Unlevered Free Cash Flow | 935.11 | -36.59 | -260.4 | 186.77 | 121.4 | 114.11 |
Change in Working Capital | 778.49 | 778.49 | -12.18 | 112.45 | 113.75 | 129.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.